These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 4146802
21. Behavioral and neurochemical effects of psychotomimetic drugs in neonate chicks. Wallach MB, Friedman E, Gershon S. Eur J Pharmacol; 1972 Feb; 17(2):259-69. PubMed ID: 5026400 [No Abstract] [Full Text] [Related]
22. Behavioral teratology of perchloroethylene in rats. Nelson BK, Taylor BJ, Setzer JV, Hornung RW. J Environ Pathol Toxicol; 1979 Dec; 3(1-2):233-50. PubMed ID: 547013 [No Abstract] [Full Text] [Related]
23. Elevated catecholamines in thirty-day-old chicken brain after depletion during development. Sparber SS, Shideman FE. Dev Psychobiol; 1970 Dec; 3(2):123-9. PubMed ID: 5527429 [No Abstract] [Full Text] [Related]
24. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain. Romero JA, Chalmers JP, Cottman K, Lytle LD, Wurtman RJ. J Pharmacol Exp Ther; 1972 Feb; 180(2):277-85. PubMed ID: 5010674 [No Abstract] [Full Text] [Related]
25. Effects of drugs on the biochemical and behavioral responses of developing organisms. Sparber SB. Fed Proc; 1972 Feb; 31(1):74-80. PubMed ID: 5061895 [No Abstract] [Full Text] [Related]
26. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition. Butcher LL, Engel J. Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767 [No Abstract] [Full Text] [Related]
27. Reversal of the reserpine-induced suppression of the conditioned avoidance response by L-dopa: correlation of behavioral and biochemical differences in two strains of mice. Seiden LS, Peterson DD. J Pharmacol Exp Ther; 1968 Feb; 159(2):422-8. PubMed ID: 5638661 [No Abstract] [Full Text] [Related]
28. Spontaneous and L-DOPA induced circus movements in cats with brain stem lesions. Poirier LJ, Langelier P, Boucher R. J Physiol (Paris); 1973 Feb; 66(6):735-54. PubMed ID: 4795092 [No Abstract] [Full Text] [Related]
29. [The behavioral and neurochemical changes in rats caused by the subchronic administration of haloperidol]. Shevchenko TP, Tolpyshev BA, Zban' LN. Eksp Klin Farmakol; 1993 Feb; 56(3):15-7. PubMed ID: 8219980 [Abstract] [Full Text] [Related]
30. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression. Moore KE, Rech RH. J Pharmacol Exp Ther; 1967 Apr; 156(1):70-5. PubMed ID: 6023602 [No Abstract] [Full Text] [Related]
31. Effect of L-dopa on delayed response and visual discrimination in cats and its relation to brain chemistry. Kitsikis A, Roberge AG, Frenette G. Exp Brain Res; 1972 Apr; 15(3):305-17. PubMed ID: 5070222 [No Abstract] [Full Text] [Related]
33. Detour learning in the chick: effect of reserpine administered during embryonic development. Sparber SB, Shideman FE. Dev Psychobiol; 1969 Apr; 2(2):56-9. PubMed ID: 5407655 [No Abstract] [Full Text] [Related]
34. Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative. Svensson TH. Eur J Pharmacol; 1973 Sep; 23(3):232-8. PubMed ID: 4746740 [No Abstract] [Full Text] [Related]
35. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines. Mason ST, Iverson SD. Nature; 1974 Apr 19; 248(5450):697-8. PubMed ID: 4151498 [No Abstract] [Full Text] [Related]
36. Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats. Ahlenius S, Engel J. Naunyn Schmiedebergs Arch Pharmakol; 1971 Apr 19; 270(4):349-60. PubMed ID: 4255378 [No Abstract] [Full Text] [Related]
37. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice. Ahlenius S. Neuropharmacology; 1974 Aug 19; 13(8):729-39. PubMed ID: 4444759 [No Abstract] [Full Text] [Related]
38. The effect of dihydroxyphenylalanine, pheniprazine and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus. McKenzie GM, Szerb JC. J Pharmacol Exp Ther; 1968 Aug 19; 162(2):302-8. PubMed ID: 4385909 [No Abstract] [Full Text] [Related]
39. [Selective increase of C14-catecholamines in the brain due to peripheral inhibition of decarboxylase]. Bartholini G, Pletscher A, Burkard WP. Helv Physiol Pharmacol Acta; 1967 Aug 19; 25(2):CR170-2. PubMed ID: 5588156 [No Abstract] [Full Text] [Related]
40. Postnatal behavioral alterations resulting from prenatal administration of dl-alphamethylparatyrosine. Lydiard RB, Sparber SB. Dev Psychobiol; 1977 Jul 19; 10(4):305-14. PubMed ID: 559606 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]